Credit Suisse (CHF 26.41 ; 7.18% ; CSGN ; CSGN.VX)
Tuesday, Credit Suisse, the Swiss bank, is expected to post 3Q EPS of SF0.54 and sales of SF6.35B, compared to EPS of SF0.48 and sales of around SF7B a year earlier. The bank was rated "hold" at Commerzbank and "neutral" at Barclays Capital while Citigroup revised its price estimate on the bank to SF28.50 from SF31.00 ("buy" rating affirmed). From a chartist point of view, the stock price is now challenging its horizontal resistance around SF27.50, and should post a consolidation in sight before further upsides towards SF30.
Pfizer (USD 19.82 ; 3.99% ; PFE ; PFE.N)
The same day, Pfizer, the US pharmaceutical firm, could report 3Q EPS of $0.56, up from $0.54 a year ago on sales of $16.5B, compared to $16.2B. The Co said last week it finalized the acquisition of Icagen, a biopharmaceutical company, for $6.00 per share in cash. Technically, the stock is accelerating on the upside after the break above its previous resistance at $19.10. Next up targets are set at $21 and $21.5, as long as $19.10 is not broken.
Sanofi (EUR 52.19 ; 1.36% ; SAN ; SASY.PA)
Thursday, Sanofi, the French drug maker may announce 3Q EPS of E1.76 vs E1.47 in the same prior year period and sales of nearly E9B, up from 7.82B. Earlier, the Co said it expected to deliver sales growth of at least 5% on average over 2012-2015 and to generate an additional E2B of cost synergies with Genzyme by 2015 through a new cost-control plan. Graphically, the stock has broken above a key resistance at E51, which should open the upside way to E56.
Unilever (EUR 24.64 ; 0.14% ; UNA ; UNc.AS)
Also on Thursday, Unilever, 3Q sales are expected at E12.0B (vs E11.5B a year earlier) and net income may reach appx. E1.2B (vs E1.25B last year). The Co announced on October 14, it agreed to acquire 82% of Concern Kalina, "the leading Russian beauty company" for 21.5B rubles or appx. E500M. Technically, the share remains bullish on both ST and MT views. The ascending 20-day moving average plays well as a support, and should push the price higher towards E25.5 in the coming days.
International Consolidated Airlines (GBp 171.5 ; 4.13% ; IAG ; IAG.L)
Friday, International Consolidated Airlines, the European airline carrier's 3Q EPS is seen at E0.15, up from E0.02 in 3Q10, on sales of E4.7B, compared to E3.9B. Group traffic measured in Revenue Passenger Kilometres rose by 4.3% on the year in September, vs +2.2% in August and +3.5% in July. The Co also approved the launch of a low-cost airline in Spain, Iberia Express, for the summer of 2012. From a technical view, the stock has validated an inverted "H&S" pattern, and is now expected to challenge 180p before further upsides to 190p.
Selection of those events which may affect the stock prices of international Large Caps